Join to View Full Profile
4101 22nd placeLubbock, TX 79410
Phone+1 806-725-8000
Fax+1 806-723-6033
Dr. Shalaby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ibrahim Shalaby is a certified oncologist in Lubbock, Texas. The Ain Shams University Faculty of Medicine graduate has special interests in Breast Cancer, Gastrointestinal Cancer, and Hematologic Oncology, with experience spanning across hereditary and familial breast/ovarian cancer, and branchiogenic carcinoma. Dr. Shalaby's research and contribution to the medical field are displayed through his participation in several clinical trials, including investigations into hormone therapy and radiation therapy. He is also a published author in the Journal of Clinical Oncology noted for his paper on the use of Palbociclib for early-stage breast cancer. In 2011, he received the Meaningful Use Stage 1 Certification from Centers for Medicare & Medicaid Services.
Education & Training
Ain Shams University Faculty of MedicineClass of 1985
Certifications & Licensure
NM State Medical License 2005 - 2027
TX State Medical License 2002 - 2025
NC State Medical License 1994 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer Start of enrollment: 2012 Feb 01
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
- Join now to see all
Publications & Presentations
PubMed
- 127 citationsRandomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET TrialStephen R. D. Johnston, Shannon Puhalla, Duncan Wheatley, Alistair Ring, Peter A. Barry
Journal of Clinical Oncology. 2019-01-20
Professional Memberships
- Fellow
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
